ssociation Between a Distinctive Autoantibody-Associated Brainstem Sensory Syndrome and Immune Checkpoint Inhibitors.

Damato V., Berretta A., Ramanathan S., Michael S., Coupe N., Payne M., Irani SR.

This case series investigates the association of a segmental, facial, antibody-associated brainstem sensory syndrome with the immune checkpoint inhibitor pembrolizumab.

DOI

10.1001/jamaneurol.2022.1824

Type

Journal article

Publication Date

2022-09-01T00:00:00+00:00

Volume

79

Pages

949 - 951

Total pages

2

Keywords

Antineoplastic Agents, Immunological, Autoantibodies, Brain Stem, Humans, Immune Checkpoint Inhibitors, Immunotherapy, Neoplasms, Syndrome

Permalink More information Close